Israel-based AI-powered clinical intelligence provider Navina has raised US$55 million in its series C funding round. The investment, led by Growth Equity at Goldman Sachs Alternatives, brings the company’s total funding to US$100 million.

Existing investors, including Vertex Ventures Israel, Grove Ventures, and ALIVE, also participated in this funding round.

Navina plans to use the funds to enhance its AI technology, automate clinical workflows, and expand into point-of-care interventions.

Founded in 2018 by Ronen Lavi and Shay Perera, Navina’s platform aims to streamline clinical workflows by converting complex patient data into actionable insights.

The company reports that over 10,000 healthcare professionals across 1,300 clinics currently use its platform.

Recent Healthcare developments